Drug Pricing Disruption

The conversation dives into the inflated prices of pharmaceuticals and the potential for global competition to drive costs down. Sal highlights the stark contrast in prices for generic drugs between countries, suggesting that regulatory bodies may prioritize pharmaceutical companies' interests. As technology evolves, the possibility of 3D printing drugs could revolutionize the industry, but it raises concerns about new forms of regulation and control over access to medications.